http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106632482-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81cdd01db91de024d36263cce0cc8e3e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3d425a40d24ba47488807c8aaca65da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f123a705c8522ef17303af24e143b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec56f925fa64e14c2b84a8cef5d4ee7
publicationDate 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106632482-A
titleOfInvention mPEG3 tenofovir disoproxil and preparation method thereof
abstract The invention belongs to the technical field of organic compound synthesis, and relates to a pharmaceutical compound mPEG 3 -tenofovir disoproxil and a preparation method thereof. mPEG 3 ‑tenofovir disoproxil has the advantages of safety and good quality. Its preparation method is to use (R)-9-(2-hydroxypropyl) adenine as a raw material, under the action of carbonate, react with triethylene glycol monomethyl ether p-toluenesulfonate to obtain the compound shown in formula II mPEG 3- (R)-9-(2-hydroxypropyl) adenine, then react with p-toluenesulfonyloxymethyl diethyl phosphate under the action of alkali to prepare mPEG 3 shown in formula III. Fovir diethyl ester, then hydrolyzed and condensed to obtain mPEG 3 ‑tenofovir disoproxil. The preparation method of mPEG 3 -tenofovir disoproxil according to the present invention has the advantages of simple method, wide sources of raw materials, mild reaction conditions, low production cost, high overall reaction yield, and relatively stable product quality.
priorityDate 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103224530-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163811548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468155677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467269804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465516258

Total number of triples: 21.